Celltrion Wins Korean Approval For Xolair Biosimilar
Firm Also Secures Supply Bids For Three Biosimilars With Major French Group
It has been a busy few weeks for Celltrion – a Korean approval for omalizumab biosimilar Omlyclo, three biosimilar supply contracts with France’s largest pharmaceutical procurement group, and new long-term data for subcutaneous infliximab.
